Raj Prabhakar
Corporate Officer/Principal bij ROCKET PHARMACEUTICALS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Raj Prabhakar is currently the Chief Business Officer & Senior Vice President at Rocket Pharmaceuticals, Inc. Prior to his current position, he held the role of Executive Director-Business Development at Imunon, Inc. from 2004 to 2015.
Following that, he served as the Senior Vice President-Business Development at Caladrius Biosciences, Inc. from 2015 to 2017.
Mr. Prabhakar completed his undergraduate studies at Massachusetts Institute of Technology and holds an MBA from Harvard Business School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
24-04-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Raj Prabhakar
Bedrijven | Functie | Begin |
---|---|---|
ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-10-2017 |
Eerdere bekende functies van Raj Prabhakar
Bedrijven | Functie | Einde |
---|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01-10-2017 |
IMUNON, INC. | Corporate Officer/Principal | 01-07-2015 |
Opleiding van Raj Prabhakar
Massachusetts Institute of Technology | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
IMUNON, INC. | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |